Nitrosonaphthol Test Qualitative – Urine Spot

The Nitrosonaphthol Test Qualitative – Urine Spot is a laboratory screening test used to detect increased tyrosine and certain tyrosine-related metabolites in a urine sample. Tyrosine is an amino acid used by the body to produce proteins, thyroid hormones, melanin and important chemical messengers. It is normally processed through a sequence of enzyme-controlled metabolic reactions.

When one of the enzymes involved in tyrosine metabolism is deficient or functioning abnormally, tyrosine or its metabolites may accumulate in the body and be excreted in urine. The nitrosonaphthol test produces a colour reaction when relevant phenolic compounds are present above the detection level of the method. Because the result is qualitative, it is generally reported as positive or negative rather than as an exact concentration.

This test may be included in a preliminary metabolic screen when a disorder of tyrosine metabolism is suspected. It may provide supportive information in the evaluation of hereditary tyrosinaemia, transient tyrosinaemia in newborns and selected amino-acid metabolism disorders. However, it is an older screening method with important limitations and cannot independently establish a diagnosis.

A positive result requires confirmation using more specific investigations such as quantitative plasma amino-acid analysis, urine organic-acid analysis, succinylacetone measurement, enzyme studies or molecular genetic testing. A negative result does not completely exclude a metabolic disorder.

What Is Tyrosine?

Tyrosine is a non-essential amino acid because the body can usually produce it from another amino acid called phenylalanine. Tyrosine is incorporated into proteins and also serves as a precursor for dopamine, noradrenaline, adrenaline, thyroid hormones and melanin.

After performing these functions, excess tyrosine is broken down through a pathway involving several enzymes. The process ultimately produces substances that can enter normal energy metabolism. A deficiency of any enzyme in this pathway may lead to the accumulation of tyrosine or intermediate metabolites.

Increased blood tyrosine is called hypertyrosinaemia. It may occur because of an inherited metabolic disorder, temporary immaturity of liver enzymes in a newborn, severe liver dysfunction, nutritional factors or other clinical circumstances. The significance depends on the patient's age, symptoms, biochemical pattern and underlying cause.

How Does the Nitrosonaphthol Test Work?

The laboratory adds specific chemical reagents, including a nitrosonaphthol reagent, to the urine specimen under controlled conditions. Tyrosine and certain related phenolic metabolites can react with the reagent and produce a characteristic colour. The observed colour reaction is interpreted according to the laboratory procedure.

The test identifies whether reactive substances are detectable but does not provide their precise concentration or determine which individual metabolite produced the reaction. Therefore, it functions as a preliminary qualitative screen rather than a definitive diagnostic or monitoring test.

Medicines, diet, nutritional status, age, liver function, sample concentration and other compounds in urine may affect qualitative metabolic screening. The result must always be interpreted with the patient's clinical information.

Why Is the Nitrosonaphthol Urine Test Performed?

A paediatrician, metabolic specialist, neurologist, hepatologist or clinical geneticist may request the test when an amino-acid metabolism disorder is suspected. It may be included with other simple metabolic screening reactions to help determine which confirmatory tests are required.

Possible reasons for testing include unexplained liver disease, developmental concerns, failure to thrive, unusual neurological symptoms, renal tubular dysfunction, abnormal newborn-screening findings or a family history of an inherited metabolic disorder.

Hereditary Tyrosinaemia

Hereditary tyrosinaemias are inherited disorders caused by deficiencies of enzymes involved in tyrosine degradation. Different enzyme defects produce different tyrosinaemia types, clinical features and metabolite patterns.

Tyrosinaemia type I is caused by deficiency of fumarylacetoacetate hydrolase. It can affect the liver, kidneys and nervous system and may lead to serious complications if not recognised and treated. Succinylacetone is the key diagnostic biomarker for tyrosinaemia type I. A qualitative nitrosonaphthol result cannot replace succinylacetone testing.

Tyrosinaemia type II is caused by deficiency of tyrosine aminotransferase and may be associated with eye lesions, painful skin changes on the palms and soles and variable developmental difficulties. Tyrosinaemia type III is rare and is caused by deficiency of 4-hydroxyphenylpyruvate dioxygenase. Diagnosis requires specialised biochemical and genetic investigations.

Transient Tyrosinaemia of the Newborn

Some premature or young newborns may temporarily develop increased tyrosine because the liver enzymes responsible for tyrosine metabolism are not yet fully mature. Nutritional factors and vitamin C status may also influence this pattern. This condition can produce a positive nitrosonaphthol reaction without hereditary tyrosinaemia.

For this reason, a positive qualitative result in a newborn must be investigated carefully. The clinician may request repeat testing, plasma amino acids, succinylacetone and other specialised studies to distinguish a temporary biochemical change from an inherited disorder.

Other Metabolic Conditions

Tyrosine or related metabolites may also be increased in severe liver dysfunction and selected disorders affecting amino-acid transport or metabolism. The nitrosonaphthol test does not distinguish among these causes. Clinical history and confirmatory laboratory investigations are essential.

Who May Need This Test?

The test may be considered for infants or children with abnormal newborn-screening results, unexplained liver enlargement, jaundice, poor growth, renal tubular abnormalities, unusual odour, neurological symptoms, developmental delay or a suspected inherited metabolic disorder.

It may also be requested when another laboratory investigation has shown increased tyrosine or when a family member has a diagnosed disorder of tyrosine metabolism. The test is not intended as a general health screen for people without relevant clinical findings.

Symptoms That May Lead to Metabolic Evaluation

Symptoms vary significantly according to the underlying disorder and may include:

• Poor feeding or repeated vomiting.
• Failure to gain weight normally.
• Persistent jaundice or liver enlargement.
• Unexplained liver dysfunction.
• Easy bruising or bleeding.
• Renal tubular dysfunction or abnormal urine findings.
• Eye pain, excessive tearing or sensitivity to light.
• Painful thickening of the skin on the palms or soles.
• Developmental delay or neurological abnormalities.
• An abnormal newborn metabolic-screening result.

These findings have many possible causes and do not prove that a tyrosine-metabolism disorder is present. Urgent medical evaluation is particularly important for an unwell infant or a patient with evidence of significant liver disease.

Sample Requirements

The test requires a fresh spot urine sample rather than urine collected over 24 hours. A spot sample is a single urine specimen collected at one point in time. The laboratory may request approximately 10 to 15 mL or another volume according to its testing protocol.

The sample should be collected in a clean, dry, sterile or laboratory-approved urine container. It must not be contaminated with stool, toilet water, cleaning chemicals, tissue paper or powders because contamination may interfere with testing.

How to Collect a Spot Urine Sample

1. Obtain the correct labelled container from the diagnostic centre.
2. Wash hands before collecting the specimen.
3. Clean the genital area when instructed by the laboratory.
4. Collect urine directly into the approved container without touching its inside surface.
5. Close the lid securely immediately after collection.
6. Write or verify the patient's identification and collection time.
7. Deliver the specimen promptly according to the laboratory's instructions.

For infants, the laboratory may recommend a paediatric urine-collection bag or another suitable technique. Urine squeezed from a diaper is generally unsuitable because absorbent material and contamination can affect the specimen.

Is Fasting Required?

Fasting is generally not required for a qualitative spot urine nitrosonaphthol test unless the doctor has ordered other investigations that require fasting. Patients should follow the preparation instructions issued by Focus Diagnostics or the treating specialist.

Inform the healthcare provider about current medicines, nutritional supplements, specialised formulas, recent illness, liver disease and dietary treatment. Do not stop a prescribed medicine or change a medically supervised diet without professional advice.

Specimen Handling and Storage

Urinary metabolites may change if a sample remains at room temperature for an extended period. The specimen should therefore reach the laboratory promptly. Refrigeration or freezing may be required when analysis is delayed, depending on the laboratory protocol.

The patient should not add preservatives unless specifically instructed. An incorrectly stored, contaminated or insufficient specimen may be rejected, and recollection may be required.

Understanding the Result

The result is generally reported as positive or negative. Some laboratories may also report a weak, trace or strongly positive reaction. The terminology and interpretation depend on the laboratory procedure.

Positive Nitrosonaphthol Test

A positive result indicates that tyrosine or one or more reactive tyrosine-related metabolites may be present above the test's detection threshold. It may occur with hereditary tyrosinaemia, transient neonatal tyrosinaemia, severe liver dysfunction or another metabolic condition.

A positive result is not diagnostic. The test cannot identify the particular tyrosinaemia type, determine disease severity or distinguish a hereditary disorder from a temporary elevation. Confirmatory biochemical testing is necessary.

Negative Nitrosonaphthol Test

A negative result means that the test did not detect a qualifying colour reaction in the submitted sample. It does not completely exclude tyrosinaemia or another metabolic disorder because metabolite excretion may vary, the concentration may be below the test's detection limit or the disorder may be better identified using another biomarker.

If clinical suspicion remains high, the doctor may proceed with quantitative amino-acid analysis, succinylacetone measurement or molecular testing regardless of the qualitative result.

False-Positive and False-Negative Results

Qualitative colour tests may be affected by interfering compounds, medicines, nutrition, specimen concentration, storage and subjective interpretation of the colour reaction. Transient tyrosinaemia in newborns is an important cause of a positive reaction that does not necessarily indicate hereditary tyrosinaemia.

A false-negative result may occur when metabolite concentrations are low or intermittent. These limitations are why the test should be used as a screening tool and not as the sole basis for diagnosis or treatment.

Confirmatory Tests That May Be Recommended

Depending on the patient's age and clinical findings, the doctor may recommend:

• Quantitative plasma amino-acid analysis.
• Urine amino-acid analysis.
• Urine organic-acid analysis using chromatography and mass spectrometry.
• Blood or urine succinylacetone measurement.
• Liver-function and coagulation tests.
• Kidney-function tests and assessment for renal tubular dysfunction.
• Alpha-fetoprotein measurement in patients with suspected tyrosinaemia type I.
• Enzyme-activity studies in selected circumstances.
• Molecular genetic testing for an identified or suspected enzyme defect.
• Genetic counselling for the patient and family.

Benefits of the Nitrosonaphthol Test

The test uses a non-invasive spot urine specimen and can provide a relatively simple preliminary screen for increased tyrosine-related compounds. It may help laboratories recognise a potentially abnormal metabolic pattern and direct the clinician towards more specific testing.

Its affordability and straightforward collection can be useful in selected clinical settings. However, these benefits must be balanced against its limited specificity and the availability of modern quantitative methods.

Limitations of the Test

The Nitrosonaphthol Test is qualitative and does not measure the exact concentration of tyrosine. It cannot determine the particular enzyme deficiency, establish the type of tyrosinaemia or assess the severity of disease. False-positive and false-negative reactions are possible.

Modern laboratory methods such as tandem mass spectrometry, quantitative amino-acid analysis, succinylacetone measurement and genetic testing offer greater specificity. Therefore, treatment should never be started or excluded solely on the basis of this qualitative reaction.

Nitrosonaphthol Urine Test at Focus Diagnostics

The Nitrosonaphthol Test Qualitative – Urine Spot is available under the pathology and bio-chemistry department at a listed price of ₹300. Patients should confirm the current price, required urine volume, specimen container, preparation instructions and expected reporting time while booking.

Bring the doctor's prescription and previous metabolic or newborn-screening reports whenever available. Clinical and family-history information can help the laboratory and treating specialist interpret the screening result appropriately.

Important Patient Instructions

• Collect a fresh spot urine sample in the approved container.
• Avoid contamination with stool, toilet water or cleaning chemicals.
• Submit the sample promptly and follow all storage instructions.
• Inform the doctor about medicines, supplements and specialised diets.
• Do not interpret a positive result as a confirmed diagnosis.
• Complete all recommended confirmatory investigations.

Medical Disclaimer

This information is intended for general education and does not replace professional medical advice, diagnosis or treatment. The Nitrosonaphthol Test is a preliminary qualitative screening assay. A positive or negative result cannot independently confirm or exclude hereditary tyrosinaemia or another metabolic disorder. Every result requires interpretation by a qualified clinician and confirmation with appropriate specialised tests.